Metachronous Isolated Inguinal Lymph Node Metastasis in Rectal Carcinoma

Abstract Rectal cancers presenting with inguinal lymph node metastasis (ILNM) are rare and challenging to treat. The prevalence of ILNM in rectal carcinoma is 0.36%. ILNM can be synchronous (diagnosed within 1 year of primary treatment) or metachronous (diagnosed after 1 year of primary treatment). Metachronous inguinal lymph nodes can present as isolated solitary metastasis or along with other distant metastasis. As per the literature reviewed by us, few cases of metachronous isolated ILNM presenting after 2 years of disease-free interval have been reported to date. Here, we report two cases of mucinous-type rectal adenocarcinoma, presenting with isolated ILNM with a long disease-free interval (>2 years). Both patients were treated with inguinal lymph node dissection and have been scheduled for further treatment with curative intent. No consensus has been formed on the optimal treatment strategy for patients with metachronous isolated ILNM from rectal adenocarcinoma. However, this subset of patients should not be considered as incurable, since surgical treatment has been shown to prolong survival in various studies. Therefore, the possibility of treatment with curative intent should be considered in such patients.

Authors

Institutions

Publication Details

Journal
World Journal of Colorectal Surgery
Published
2024-10-01
DOI
https://doi.org/10.4103/wjcs.wjcs_27_24
Primary Topic
Colorectal and Anal Carcinomas
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Metachronous Isolated Inguinal Lymph Node Metastasis in Rectal Carcinoma

Dishitha Shetty, Sujai Hegde
World Journal of Colorectal Surgery
Colorectal and Anal Carcinomas
article

Metachronous Isolated Inguinal Lymph Node Metastasis in Rectal Carcinoma

Dishitha Shetty, Sujai Hegde
article en

Abstract

Abstract Rectal cancers presenting with inguinal lymph node metastasis (ILNM) are rare and challenging to treat. The prevalence of ILNM in rectal carcinoma is 0.36%. ILNM can be synchronous (diagnosed within 1 year of primary treatment) or metachronous (diagnosed after 1 year of primary treatment). Metachronous inguinal lymph nodes can present as isolated solitary metastasis or along with other distant metastasis. As per the literature reviewed by us, few cases of metachronous isolated ILNM presenting after 2 years of disease-free interval have been reported to date. Here, we report two cases of mucinous-type rectal adenocarcinoma, presenting with isolated ILNM with a long disease-free interval (>2 years). Both patients were treated with inguinal lymph node dissection and have been scheduled for further treatment with curative intent. No consensus has been formed on the optimal treatment strategy for patients with metachronous isolated ILNM from rectal adenocarcinoma. However, this subset of patients should not be considered as incurable, since surgical treatment has been shown to prolong survival in various studies. Therefore, the possibility of treatment with curative intent should be considered in such patients.

World Journal of Colorectal SurgeryVol. 13(4)
Ruby Hall Clinic (IN)
Good health and well-being
Openalex Percentile: Top 60%
Colorectal and Anal Carcinomas
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.